Medicamen Biotech Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹43.63Cr |
Net Profits | ₹1.35Cr |
Net Profit Margins | 3.09% |
Highlights
Revenue:
Medicamen Biotech Ltd’s revenue jumped 3.1% since last year same period to ₹43.63Cr in the Q1 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -8.9% fall in its revenue since last 3-months.
Net Profits:
Medicamen Biotech Ltd’s net profit fell -67.7% since last year same period to ₹1.35Cr in the Q1 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -36.62% fall in its net profits since last 3-months.
Net Profit Margins:
Medicamen Biotech Ltd’s net profit margin fell -68.67% since last year same period to 3.09% in the Q1 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -30.43% fall in its net profit margins since last 3-months.
